Actively Recruiting

Age: 50Years +
All Genders
Healthy Volunteers
ID05304195

Exploration of Glucocerebrosidase Activity to Identify a Subpopulation Eligible for a Therapeutic Trial in Dementia With Lewy Bodies

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-11-20

236

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research focuses on the activity of an enzymatic protein: glucocerebrosidase, in dementia with lewy bodies (DLB). Indeed, the mutation of the GBA gene responsible for a decrease in the activity of glucocerebrosidase is the most frequent known genetic risk factor in DLB. However, mutations of the GBA gene are known in another pathology, Gaucher disease, in which treatments have been developed. The objective of this research is to determine if glucocerebrosidase activity is decreased in DLB. This hypothesis could open up a therapeutic perspective, with treatments already used in Gaucher disease.

CONDITIONS

Brief Title

Exploration of GCase Activity to Identify a Subpopulation Eligible for a Therapeutic Trial in Dementia With Lewy Bodies

Who Can Participate

Age: 50Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

Inclusion Criteria for patients :

  • Male or female aged ≥ 50 years old
  • Presence of an accompanying person
  • Dementia with lewy bodies according to the revised criteria of Mc Keith 2017

Inclusion Criteria for controls:

  • Male or female aged ≥ 50 years old
  • Absence of cognitive impairment and clinical element for a neurodegenerative disease

Exclusion Criteria for patients:

  • Other neurodegenerative disease
  • Gaucher disease

Exclusion Criteria for controls:

  • Neurodegenerative disease
  • Cognitive impairment of all causes
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Centre de neurologie Cognitive

Paris, France, France, 75010

Actively Recruiting

Loading map...

Research Team

C

Claire HOURREGUE, MD

C

Claire PAQUET, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Comparison of Cardiac [18F]-MFBG PET Versus [123I]-MIBG SPEC...

Parkinson Disease

Actively Recruiting

2 locations

[18F]F-DOPA Imaging in Patients With Autonomic Failure

Autonomic Failure

Actively Recruiting

1 location

Clinical Trial to Evaluate Cognitive, Neuropsychiatric, and ...

Dementia With Lewy Bodies

Actively Recruiting

8 locations

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here